Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer. | Cell Death Dis | 2023 | 37770435 | PubTator, text mining | PubMed |
| CircRNAs: A Promising Star for Treatment and Prognosis in Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 37762497 | PubTator, text mining | PubMed |
| AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation. | Antioxidants (Basel) | 2023 | 37759984 | PubTator, text mining | PubMed |
| The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets. | Brain Sci | 2023 | 37759870 | PubTator, text mining | PubMed |
| Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway. | Cancer Cell Int | 2023 | 37743467 | PubTator, text mining | PubMed |
| YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis. | Nat Commun | 2023 | 37739954 | PubTator, text mining | PubMed |
| Sources, morphology, phytochemistry, pharmacology of Curcumae Longae Rhizoma, Curcumae Radix, and Curcumae Rhizoma: a review of the literature. | Front Pharmacol | 2023 | 37719857 | PubTator, text mining | PubMed |
| The TGFβ→TAK1→LATS→YAP1 Pathway Regulates the Spatiotemporal Dynamics of YAP1. | Mol Cells | 2023 | 37706312 | PubTator, text mining | PubMed |
| Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance. | J Transl Med | 2023 | 37705098 | PubTator, text mining | PubMed |
| NRP1 transduces mechanical stress inhibition via LATS1/YAP in hypertrophic scars. | Cell Death Discov | 2023 | 37704618 | PubTator, text mining | PubMed |
| Review of possible mechanisms of radiotherapy resistance in cervical cancer. | Front Oncol | 2023 | 37692844 | PubTator, text mining | PubMed |
| Patient-Derived Organoids as a Promising Tool for Multimodal Management of Sarcomas. | Cancers (Basel) | 2023 | 37686615 | PubTator, text mining | PubMed |
| CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. | Mol Cancer | 2023 | 37684641 | PubTator, text mining | PubMed |
| Correction: Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer. | J Exp Clin Cancer Res | 2023 | 37674173 | PubTator, text mining | PubMed |
| SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway. | iScience | 2023 | 37664594 | PubTator, text mining | PubMed |
| Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma. | Front Pharmacol | 2023 | 37663266 | PubTator, text mining | PubMed |
| Roles of salt‑inducible kinases in cancer (Review). | Int J Oncol | 2023 | 37654200 | PubTator, text mining | PubMed |
| Clinicopathological Significance of DUB3 Expression in Non-small Cell Lung Cancer and Relationship Between DUB3 Expression and LATS1 Expression. | In Vivo | 2023 | 37652526 | PubTator, text mining | PubMed |
| Genetic analysis of low-grade adenosquamous carcinoma of the breast progressing to high-grade metaplastic carcinoma. | Breast Cancer Res Treat | 2023 | 37650999 | PubTator, text mining | PubMed |
| Identification of circRNA-associated ceRNA networks in peripheral blood mononuclear cells as potential biomarkers for chronic obstructive pulmonary disease. | Biosci Rep | 2023 | 37650285 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=16